Stock & Company Details
Immucell Corp. $ICCC
Price:
N/A
N/A
9.1M
$96M
52 Week High:
N/A
10 Day Average Volume:
N/A
-171.43
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ICCC technical indicators
Latest Immucell Corp. (ICCC) indicator readings as of 2026-10-29.
ICCC's 14-day RSI is 51.8, in neutral territory. At $10.32 it is trading 16.7% above its 200-day moving average of $8.84, and above its 50-day average of $10.04. Price sits in the middle of its Bollinger Bands ($9.46 to $11.01). ADX reads 18.4, indicating a range-bound market rather than a trend.
Overview
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. It has two segments Scours and Mastitis. The company generates the majority of its revenue from the United States.
Finance Bot
Ask your questions
Start by typing a question below.
